Align Technology
ALGN
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$198m
Combined value at quarter end
Last quarter
0 bought
1 sold or trimmed
Fund portfolios
1
Funds holding it
See which
Price at Q2 ’26 end
$168.66
-1.6% in the quarter
Share price change by quarter
+5.3%Q3 ’24
-18.0%Q4 ’24
-23.8%Q1 ’25
+19.2%Q2 ’25
-33.9%Q3 ’25
+24.7%Q4 ’25
+9.8%Q1 ’26
-1.6%Q2 ’26
Managers holding it, by quarter
2Q4 ’23
2Q1 ’24
3Q2 ’24
3Q3 ’24
3Q4 ’24
2Q1 ’25
2Q2 ’25
1Q3 ’25
1Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| Ruane, Cunniff & Goldfarb (Sequoia) | 3.1%$198m | Trimmed -2.9% |
About the company
- Sector
- Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 71m at 31 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$660m2013
$845m2015
$1.5bn2017
$2.4bn2019
$4.0bn2021
$3.9bn2023
$4.0bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $4.0bn | $410m |
| 2024 | $4.0bn | $421m |
| 2023 | $3.9bn | $445m |
| 2022 | $3.7bn | $362m |
| 2021 | $4.0bn | $772m |
| 2020 | $2.5bn | $1.8bn |
| 2019 | $2.4bn | $443m |
| 2018 | $2.0bn | $400m |
| 2017 | $1.5bn | $231m |
| 2016 | $1.1bn | $190m |
| 2015 | $845m | $144m |
| 2014 | $762m | $146m |
| 2013 | $660m | $64.3m |
In fund portfolios
| Sequoia FundRuane, Cunniff & Goldfarb (Sequoia) | 2.1% |